Journal Report

LEUKEMIA & LYMPHOMA

Download PDF
Journal Information
Journal Title
LEUKEMIA & LYMPHOMA
Publisher
TAYLOR & FRANCIS LTD
ISSN
1042-8194
E-ISSN
1029-2403
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Projected population size by treatment line in diffuse large B-cell lymphoma in the United States, 2024–2028
Xiaoxiao Lu, Alex Bokun, Veronica Ashton et al.
2026-11-5 Pages 1-10
DOI: 10.1080/10428194.2026.2755204
Perniosis-like lesions as an extramedullary manifestation preceding a chronic myelomonocytic leukemia diagnosis: a clinicopathological and molecular description
Francisco Javier Díaz de la Pinta, Juan Torre-Castro, Rosario Haro Ramos et al.
2026-11-5 Pages 1-4
DOI: 10.1080/10428194.2026.2758498
Patient empowerment in Hodgkin Lymphoma (HL) through continuously accessible information resources
Karolin Behringer, Peter Borchmann
2026-11-5 Pages 1-2
DOI: 10.1080/10428194.2026.2753810
Post-transplant maintenance in acute myeloid leukemia in Italy: results of the GITMO-maintenance survey
Michele Malagola, Luca Castagna, Daniele Avenoso et al.
2026-11-3 Pages 1-5
DOI: 10.1080/10428194.2026.2758497
First-line pemigatinib in a myeloid/lymphoid neoplasm with FGFR1 rearrangement: shifting the current treatment paradigm
Christos Stafylidis, Eleni Variami, Eleftheria Lakiotaki et al.
2026-11-2 Pages 1-7
DOI: 10.1080/10428194.2026.2757354
Primary CNS lymphoma mimicking brain metastases with successful glucarpidase rescue and methotrexate rechallenge
Lauren M. Webb, Jamal Mohamud, Edward Avila et al.
2026-11-2 Pages 1-3
DOI: 10.1080/10428194.2026.2757344
Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline
Jeff P. Sharman, David Andorsky, Jason Melear et al.
2026-11-2 Pages 1-11
DOI: 10.1080/10428194.2026.2748719
The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia
Carol Yuk Man Cheung, Nurul Aidah Abdul Halim, Gin Gin Gan et al.
2026-10-30 Pages 1-19
DOI: 10.1080/10428194.2026.2743349
Acute promyelocytic leukemia with clonal hematopoiesis: a case study of APL in complete molecular remission transitioning to MDS/MPN and its clinical implications
Anetta Marcinek, Katrin Schweneker, Manja Meggendorfer et al.
2026-10-30 Pages 1-3
DOI: 10.1080/10428194.2026.2755196
Chronic myelomonocytic leukemia associated with lymphoid neoplasms
Julia Bannatyne, Iñigo Romon, Juan J. Domínguez et al.
2026-10-30 Pages 1-5
DOI: 10.1080/10428194.2026.2753811
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 05:07